In the present study, BC cases had a higher frequency of the Greenlandic BRCA1 founder mutation compared with their controls (4.8% in cases vs. 1.4% in controls; Table 2); however, the BRCA1 mutation alone could not explain the frequency of BC cases in our study population. The gene discussed is BRCA1; the disease is breast cancer.